GENO · Genovis AB
20.05
SEKUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
kr1.26B
PE
59.50
EV/EBITDA
32.9
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- Engulfing Bearish
Key Fundamentals
EPS 3 yr Growth
109.00%
EBITDA Margin
30.80%
Operating Cashflow
kr32m
Free Cash Flow Return
10.00%
ROIC
7.40%
Interest Coverage
10.50
Quick Ratio
6.90
Performance
52 weeks range
Low 15.64 - 29
Trade Value (12mth)
US$40,726.00
1 week
0.53%
1 month
-1.76%
YTD
-12.55%
1 year
-30.58%
All time high
103.50
Additional Data
Shares Outstanding (Fully Diluted)
67m
HALO Sector
Healthcare
Next Company Report Date
11-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
SEK
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
News & Announcements
No announcements available.